Jim Palma, Chief Executive Officer at TargetCancer Foundation, shared a post on LinkedIn:
“Very hard to believe we’re almost a week away from the Target Cancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers!
I’m especially excited about our agenda this year.
Some highlights:
– The Precision Patient: A Case For Seeking Out Innovative, Science-Based Therapy for Patients with Metastatic Cancer featuring Allen Chankowsky.
– Advancing Innovation in Rare Cancer Treatment, with clinical insights from Razelle Kurzrock, Vivek Subbiah, Lauren Banks as well as a FDA perspective from Peter Bross.
– Focus on discovery in NUT Carcinoma as well as functional precision medicine in rare cancers featuring Christopher French and Taran G.
– Germline genetics in pediatric cancers featuring Kristin Zelley and Catherine Skefos.
– Addressing barriers to rare cancer clinical trials with Jennifer Levin Carter and Wafik S. El-Deiry.
– And closing the day with The Power of Personal Experience: Patient and Caregivers As Drivers of Rare Cancer Research, featuring Corrie Painter, Michael Casaus and Suzanne Vincze.
Free registration is open and space remains!
Click here to learn more.”
